ChemicalBook--->CAS DataBase List--->2918768-08-6

2918768-08-6

2918768-08-6 Structure

2918768-08-6 Structure
IdentificationBack Directory
[Name]

CP-4126/CO-101
[CAS]

2918768-08-6
[Synonyms]

CP-4126/CO-101
CP-4126 hydrochloride
Gemcitabine elaidate hydrochloride, 10 mM in DMSO
[Molecular Formula]

C27H43F2N3O5.ClH
[MOL File]

2918768-08-6.mol
[Molecular Weight]

564.11
Chemical PropertiesBack Directory
[form ]

Solid
[color ]

White to off-white
Hazard InformationBack Directory
[Uses]

Gemcitabine elaidate (CP-4126) hydrochloride is lipophilic pro-agent of Gemcitabine. Gemcitabine elaidate hydrochloride is converted to Gemcitabine by esterases in order to be phosphorylated. Gemcitabine elaidate hydrochloride exhibits anti-tumor activity[1][2].
[in vivo]

Gemcitabine elaidate (25-120 mg/kg; i.p. every 3 days for 5 doses) hydrochloride inhibits the solid tumor xenografts growth of non-small cell lung cancer (EKVX), non-classifiable sarcoma (MHMX), fibrous histiocytoma (TAX II-1), malignant melanoma (THX), prostate cancer (CRL-1435), pancreatic cancer (PANC-1)[1].
? Gemcitabine elaidate (10-20 mg/kg; p.o. every 3 days for 5 doses) hydrochloride shows acceptable toxicity and significant antitumor activity in the colon cancer xenograft Co6044 bearing mice[1].
? Gemcitabine elaidate (p.o. once daily for 5 doses) hydrochloride shows a favorable toxicity and antitumor activity, while the dose of 15 mg/kg is highly toxic in the human colon cancer xenograft Co6044[1].

Animal Model:Female BALB/c nude (nu/nu) mice (5-8 weeks; 20-27 g) were bearing tumor of EKVX, H-146, MHMX, TAX II-1, OHS, THX, MA-11, CRL-1435, PANC-1 and MiaPaCa-2, respectively[1]
Dosage:25-120 mg/kg
Administration:I.p. every 3 days for 5 doses
Result:Inhibited the growth of EKVX, MHMX, TAX II-1, THX, CRL-1435 and PANC-1, with T/C values of 7%, 1%, 30%, 7%, 9%, and 12%, respectively.
[References]

[1] Bergman AM, et, al. Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models. Invest New Drugs. 2011 Jun;29(3):456-66. DOI:10.1007/s10637-009-9377-7
[2] Adema AD, et, al. Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel. Int J Oncol. 2010 Jan;36(1):285-94. PMID:19956857
Spectrum DetailBack Directory
[Spectrum Detail]

CP-4126/CO-101(2918768-08-6)1HNMR
2918768-08-6 suppliers list
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Telephone: 021-52996696,15000506266 15000506266
Website: http://www.bioll.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Telephone: 18916372613
Website: www.shyuanye.com
Company Name: NewCan Biotech Limited  
Telephone: +86-571-86912261 19975279805
Website: https://www.newcanbio.com/
Company Name: Shanghai Tachizaki Biomedical Research Center  
Telephone: 18014399201
Website: http://www.chemlab-tachizaki.com/
Company Name: Wuhan Jingkangen Biomedical Technology Co., Ltd  
Telephone: 13720134139 086-15871494362 13720134139
Website: https://www.jknbiochem.com
Company Name: Nantong QuanYi Biotechnology Co., Ltd  
Telephone: 0513-66337626 18051384581
Website: https://www.chemhifuture.com/
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Telephone: 021-65675885 18964387627
Website: http://www.efebio.com
Company Name: Shanghai Aladdin Biochemical Technology Co.,Ltd.  
Telephone: 6206333 13167063860
Website: www.aladdin-e.com/
Company Name: TargetMol Chemicals Inc.  
Telephone: 15002134094
Website: https://www.targetmol.cn/
Company Name: Shanghai Amole Biotechnology Co., Ltd.  
Telephone: 13370042665 18916960931
Website: www.amole.com.cn/
Tags:2918768-08-6 Related Product Information
25316-40-9 941678-49-5 154-17-6 474645-27-7 4474-91-3 555-60-2